[go: up one dir, main page]

CN117122734B - Preparation method of bone repair raw material, bone repair raw material and application thereof - Google Patents

Preparation method of bone repair raw material, bone repair raw material and application thereof Download PDF

Info

Publication number
CN117122734B
CN117122734B CN202311096242.0A CN202311096242A CN117122734B CN 117122734 B CN117122734 B CN 117122734B CN 202311096242 A CN202311096242 A CN 202311096242A CN 117122734 B CN117122734 B CN 117122734B
Authority
CN
China
Prior art keywords
solution
bone repair
tricalcium phosphate
magnesium
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202311096242.0A
Other languages
Chinese (zh)
Other versions
CN117122734A (en
Inventor
崔嵬
洪东立
陈进庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Banglai Medical Technology Co ltd
Original Assignee
Changzhou Banglai Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou Banglai Medical Technology Co ltd filed Critical Changzhou Banglai Medical Technology Co ltd
Priority to CN202311096242.0A priority Critical patent/CN117122734B/en
Publication of CN117122734A publication Critical patent/CN117122734A/en
Priority to PCT/CN2024/114504 priority patent/WO2025044976A1/en
Application granted granted Critical
Publication of CN117122734B publication Critical patent/CN117122734B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses a preparation method of a bone repair raw material, the bone repair raw material and application thereof. A preparation method of a bone repair raw material comprises the following steps of (i) preparing a mixed solution of calcium salt and magnesium salt as a first solution, preparing a phosphate solution, adjusting the pH value to 9.5-10.5 by using alkali liquor as a second solution, (ii) heating and mixing the first solution and the second solution, reacting at 60-95 ℃ under the condition of stirring, and (iii) centrifugally separating a suspension obtained after the reaction in the step (ii) to obtain a precipitate, cleaning, and spray-drying the cleaned precipitate to obtain a powdery porous bone repair raw material. The preparation method has mild reaction conditions and reduces the production cost, and the prepared bone repair raw material is a low-density porous powder material and has high combination property with high polymer materials such as collagen.

Description

Preparation method of bone repair raw material, bone repair raw material and application thereof
Technical Field
The invention relates to a preparation method of a bone repair raw material, in particular to a preparation method of a magnesium-containing tricalcium phosphate bone repair powder raw material, which can be used for preparing a bone repair body.
Background
As the aging degree of the population further increases, the incidence of bone injuries caused by various chronic diseases, traffic accidents, industrial injuries and sports injuries increases year by year, and development of novel artificial bone materials for repairing bone defects is urgently needed. The existing bone repair materials mainly comprise hydroxyapatite, and show certain biocompatibility after being implanted into a body, but hardly degrade and metabolize in the body. Studies have shown that hydroxyapatite has no obvious change after being implanted into a bone defect site in vivo for several years, thus preventing the growth of new bone, see literature 1:Dorozhkin S.V.,Epple M.Biological and medical significance of calcium phosphates.Angew.Chem.Int.Ed.2002,41:3130-3146.
The tricalcium phosphate material has better degradation performance compared with hydroxyapatite, and can be chemically combined with bone after being implanted into a body. However, hydroxyapatite is easily crystallized in liquid phase synthesis, and tricalcium phosphate is difficult to form. As such, tricalcium phosphate raw materials are generally prepared by high-temperature calcination or solid-phase reaction at a temperature of more than 1000 ℃, consume a large amount of energy, and have dense micron-sized powder product particles, high density and irregular surface, and are difficult to meet the requirements of 3D printing and application of some novel bone repair composite materials, see literature 2:Yadav M.K.,Pandey V.and et al.A low-cost approach to develop silica doped Tricalcium Phosphate(TCP)scaffold by valorizing animal bone waste and rice husk for tissue engineering applications.Ceram.Int.2022,48:25335-25345.
Patent ZL201610290891.8 discloses a method for preparing beta-phase tricalcium phosphate crystal material under low temperature condition, which comprises mixing Ca (Mg, sr) and P source at normal temperature to prepare amorphous calcium phosphate material, then placing into a hydrothermal reaction kettle, crystallizing at high temperature and high pressure (160-250 ℃ and 1.5 MPa) to form tricalcium phosphate crystal material, and the grain size is 30-100nm. Compared with the traditional process for preparing the tricalcium phosphate material by high-temperature calcination, the method converts amorphous calcium phosphate into tricalcium phosphate crystals by a hydrothermal condition of 160-250 ℃ and 1.5MPa, so that the production cost can be effectively reduced, and the nanoscale tricalcium phosphate powder is obtained. However, the hydrothermal condition of high temperature and high pressure of the method makes the preparation method difficult to be applied on a large scale, and the obtained nano tricalcium phosphate powder often causes powder to fall off to induce inflammatory reaction due to weak binding force when being applied to a novel bone repair composite material.
Therefore, there is a need to develop a tricalcium phosphate bone repair material suitable for preparing bone repair body, which has milder preparation conditions and stronger binding force of composite materials.
Disclosure of Invention
The invention aims to provide a preparation method of a bone repair raw material, which has mild reaction conditions and reduced production cost, wherein the prepared bone repair raw material is a low-density porous powder material and has good binding property with high polymer materials such as collagen. The bone repair raw material is suitable for preparing bone repair bodies, wherein the bone repair raw material has better combination property and dispersibility in high polymer materials such as collagen, and solves the problems of falling and inflammation of nano tricalcium phosphate powder in the application process.
The first aspect of the present invention provides a method for preparing a bone repair material, comprising the steps of:
(i) Preparing a mixed solution of calcium salt and magnesium salt as a first solution, preparing a phosphate solution, and adjusting the pH to 9.5-10.5 by alkali liquor as a second solution;
(ii) Heating and mixing the first solution and the second solution, and reacting under the conditions of 60-95 ℃ and stirring;
(iii) And (3) centrifugally separating the suspension obtained after the reaction in the step (ii) to obtain a precipitate, cleaning, and spray-drying the cleaned precipitate to obtain the powdery porous bone repair raw material.
In a preferred embodiment, the molar concentration ratio of calcium ions to magnesium ions in the first solution is 6-10.
In a more preferred embodiment, the molar concentration of calcium ions in the first solution is 0.01-0.9 mol/L, more preferably 0.1-0.8 mol/L, still more preferably 0.2-0.6 mol/L. For example, the molar concentration of calcium ions is 0.01mol/L, 0.05mol/L, 0.08mol/L, 0.1mol/L, 0.2mol/L, 0.3mol/L, 0.4mol/L, 0.5mol/L, 0.6mol/L, 0.7mol/L or 0.8mol/L.
In a more preferred embodiment, the molar concentration of magnesium ions in the first solution is 0.001 to 0.15mol/L, more preferably 0.01 to 0.15mol/L, still more preferably 0.01 to 0.1mol/L, and especially 0.05 to 0.08mol/L. For example, the molar concentration of magnesium ions is 0.001mol/L、0.005mol/L、0.008mol/L、0.01mol/L、0.02mol/L、0.03mol/L、0.04mol/L、0.05mol/L、0.06mol/L、0.07mol/L、0.08mol/L、0.09mol/L、0.1mol/L、0.12mol/L or 0.15mol/L.
Optionally, the concentration of the calcium salt is 1 to 100g/L, more preferably 30 to 100g/L, still more preferably 50 to 100g/L, still more preferably 60 to 90g/L, in particular 80 to 90g/L, for example 80g/L, 82g/L, 84g/L, 86g/L, 88g/L or 90g/L by weight. Optionally, the concentration of magnesium salt is 0.4 to 40g/L, more preferably 0.4 to 30g/L, still more preferably 5 to 30g/L, still more preferably 15 to 30g/L, in particular 20 to 30g/L, for example 20g/L, 22g/L, 24g/L, 25g/L, 27g/L or 29g/L.
In a preferred embodiment, after the first solution and the second solution are mixed, the molar ratio of calcium ions to phosphate ions is 1.1-1.5.
In a more preferred embodiment, the molar concentration of phosphate in the second solution is 0.008 to 0.8mol/L, more preferably 0.01 to 0.8mol/L, still more preferably 0.05 to 0.8mol/L, and especially 0.1 to 0.5mol/L. For example, the molar concentration of phosphate is 0.008mol/L、0.009mol/L、0.01mol/L、0.02mol/L、0.03mol/L、0.04mol/L、0.05mol/L、0.06mol/L、0.07mol/L、0.08mol/L、0.09mol/L、0.1mol/L、0.2mol/L、0.3mol/L、0.4mol/L、0.5mol/L、0.6mol/L、0.7mol/L or 0.8mol/L.
Optionally, the concentration of phosphate in the second solution is 1-100 g/L, more preferably 30-100 g/L, still more preferably 50-90 g/L, still more preferably 70-90 g/L, especially 80-90 g/L, for example 81g/L, 83g/L, 84g/L, 85g/L, 87g/L or 88g/L by weight.
Further, the first solution and the second solution are mixed in equal volumes.
In a preferred embodiment, the solvent of the first solution is water and the solvent of the second solution is water. Alternatively, the solvent of the first solution is selected from the group consisting of one or more of methanol, ethanol, and water, and the solvent of the second solution is selected from the group consisting of one or more of methanol, ethanol, and water.
In a preferred embodiment, the calcium salt is selected from one or more of anhydrous calcium chloride, calcium chloride dihydrate and calcium nitrate tetrahydrate, the magnesium salt is selected from magnesium chloride hexahydrate and/or magnesium nitrate hexahydrate, and the phosphate salt is selected from a combination of more of one of disodium hydrogen phosphate, diammonium hydrogen phosphate and sodium hydrogen phosphate. In a preferred embodiment, the lye is ammonia or sodium hydroxide.
In a preferred embodiment, in the step (i), ammonia is used to adjust the pH of the second solution to 9.8-10.2. More preferably, the pH of the second solution is 9.8-10.0.
In a preferred embodiment, in step (ii), the first solution and the second solution are heated to 60-95 ℃ and mixed.
In a preferred embodiment, in step (ii), the stirring speed is 100 to 500rpm.
In a preferred embodiment, in step (ii), the reaction is carried out under atmospheric pressure.
In a preferred embodiment, in step (iii), the cleaned precipitate is spray dried using a spray dryer with an inlet air temperature of 240-300 ℃, an outlet air temperature of 120-150 ℃ and a feed rate of 30-200 ml/min.
In a preferred embodiment, in step (iii), the precipitate is added into water for centrifugal washing for a plurality of times, the washed precipitate is added into water with the mass of 5-20 times, and the mixture is stirred uniformly to form slurry, and then spray drying is carried out.
In a specific and preferred embodiment, the preparation method is carried out as follows:
dissolving calcium salt and magnesium salt in water to obtain a first solution, wherein the concentration of the calcium salt is 1-100 g/L, and the concentration of the magnesium salt is 0.4-40 g/L;
dissolving phosphate in water, and regulating the pH to 9.5-10.5 by using ammonia water to obtain a second solution, wherein the concentration of the phosphate is 1-100 g/L;
Heating the first solution and the second solution with equal volumes to 60-95 ℃ and then mixing, and reacting at normal pressure under stirring conditions to generate suspension, wherein the stirring speed is 100-500 rpm;
and centrifugally separating the suspension obtained after the reaction to obtain a precipitate, centrifugally cleaning the precipitate with water for 4-8 times, adding the cleaned precipitate into water with the mass of 5-20 times, uniformly stirring to form slurry, and treating the slurry into micron-sized porous tricalcium phosphate powder by using a spray dryer to obtain the bone repair raw material, wherein the air inlet temperature of the spray dryer is 240-300 ℃, the air outlet temperature is 120-150 ℃, and the feeding rate is 30-200 mL/min.
The second aspect of the present invention provides a bone repair material prepared by the above method, wherein the bone repair material is in a powder form and has a porous structure, and the particle size is 1-20 μm.
In a third aspect, the present invention provides the use of the bone repair material in the preparation of a bone repair body.
Due to the application of the technical scheme, compared with the prior art, the invention has the following advantages:
According to the preparation method, the calcium/magnesium mixed solution and the phosphate solution are subjected to direct wet chemical reaction at the normal pressure of 60-95 ℃ to generate the magnesium-containing tricalcium phosphate suspension, the magnesium-containing tricalcium phosphate suspension is shaped through spray drying to obtain the low-density porous magnesium-containing tricalcium phosphate powder with the particle size of 1-20 mu m, the reaction condition is mild, the preparation process is simple, the preparation process is avoided by using a high-temperature calcination process or through a solid phase reaction, the porous structure can provide better binding force and dispersibility in the process of preparing the bone prosthesis, and the obtained powder material can effectively promote the osteogenic differentiation of bone tissue cells and promote the generation of new bones. In the process of preparing the bone prosthesis by the powder material, the special porous structure can lead tricalcium phosphate and high polymer (such as collagen) to form an interlocking structure, thereby remarkably improving the body binding property and solving the problems of falling and inflammation of nanometer tricalcium phosphate powder in the application process.
Drawings
In order to more clearly illustrate the technical solutions of the present invention, the drawings that are needed in the description of the embodiments will be briefly described below, it being obvious that the drawings in the following description are only some embodiments of the present invention, and that other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
Fig. 1 is an XRD pattern of the powder material prepared in example 1 of the present invention.
Fig. 2 is an SEM micro morphology of the powder material prepared in example 1 of the present invention.
FIG. 3 is an interpenetrating microstructure of the powder material prepared in example 1 of the present invention after being compounded with collagen.
Fig. 4 is an XRD pattern of the powder material prepared in example 2 of the present invention.
Fig. 5 is an XRD pattern of the powder material prepared in comparative example 1.
Fig. 6 is an XRD pattern of the powder material prepared in comparative example 2.
Detailed Description
Preferred embodiments of the present invention will be described in detail below with reference to the attached drawings so that the advantages and features of the present invention can be more easily understood by those skilled in the art. The description of these embodiments is provided to assist understanding of the present invention, but is not intended to limit the present invention. In addition, technical features of the embodiments of the present invention described below may be combined with each other as long as they do not collide with each other.
Compared with hydroxyapatite, the tricalcium phosphate material has better degradation performance, so that the tricalcium phosphate material has remarkable advantages in application of bone repair materials. However, since the solubility product (10-57.8) of hydroxyapatite is far lower than that of tricalcium phosphate material (10-28.7), hydroxyapatite is easily crystallized in liquid phase synthesis, and tricalcium phosphate is difficult to form. Tricalcium phosphate raw materials are usually prepared by high-temperature calcination or solid-phase reaction at a temperature of 1000 ℃ or higher, consume a large amount of energy, and have micron-sized product particles, high density and irregular surface. At present, although some manufacturers can stably produce tricalcium phosphate powder raw materials, most of the raw materials are calcined through a solid phase reaction method, the powder is crushed through mechanical grinding, the manufacturing cost is high, the sintered crystal grains are large, the shape is in an irregular geometric shape, and the fluidity is poor in the process of preparing the liquid phase composite material. The application provides a novel method for preparing magnesium-containing tricalcium phosphate powder based on wet chemical reaction, which is characterized in that magnesium-containing tricalcium phosphate suspension is generated by direct wet chemical reaction in a 60-95 ℃ normal pressure environment, and the low-density porous magnesium-containing tricalcium phosphate powder with the thickness of 1-20 mu m is obtained by a special forming mode of spray drying, and the porous structure can provide better binding force and dispersibility in the process of preparing a bone repair body.
Firstly, the method solves the problem that tricalcium phosphate cannot be prepared at low temperature, develops a tricalcium phosphate low-temperature chemical synthesis process by regulating and controlling an ion combination path in a liquid phase reaction, has the reaction temperature as low as 60-95 ℃, greatly reduces the production cost by more than 90%, and avoids the severe reaction conditions (160-250 ℃ and 1.5 MPa) of high-temperature calcination (more than 1000 ℃) and hydrothermal synthesis. And secondly, the powder material prepared by the application is doped with active magnesium element, so that osteogenic differentiation of bone tissue cells can be effectively promoted, and new bone formation can be promoted. Aiming at the problems of weak binding force, poor dispersibility and the like of the tricalcium phosphate material in the application process, the active tricalcium phosphate material synthesized by the low-temperature wet chemical method forms micron-sized low-density porous powder through a spray drying process, and the special porous structure can enable the tricalcium phosphate powder to form an interlocking structure with high polymers such as collagen and the like in the preparation process of the bone repair body, so that the tricalcium phosphate material has good dispersibility and bondability, solves the problems of falling and inflammation of the nanometer tricalcium phosphate powder in the application process, and has important practical application value.
The preparation method of the bone repair raw material specifically comprises the following steps:
(1) And dissolving calcium salt and magnesium salt in water to obtain a first solution, wherein the concentration of the calcium salt is 1-100 g/L, and the concentration of the magnesium salt is 0.4-40 g/L. Further, the molar ratio of calcium ion to magnesium ion is 6 to 10, more preferably 7 to 10, still more preferably 7 to 9, for example, 6.0, 7.0, 8.0, 9.0, 10.0.
(2) And dissolving phosphate in water, and adjusting the pH to 9.5-10.5 by using ammonia water to obtain a second solution, wherein the concentration of the phosphate is 1-100 g/L.
(3) Heating the first solution and the second solution with equal volumes to 60-95 ℃ and then mixing, and carrying out wet chemical reaction under normal pressure under stirring conditions, wherein the stirring speed is 100-500 rpm. The molar ratio of calcium ions to phosphate ions is 1.1 to 1.5, preferably 1.1 to 1.4, more preferably 1.2 to 1.4, for example 1.1, 1.2, 1.3, 1.4, 1.5.
(4) Centrifuging the suspension after wet chemical reaction to obtain a precipitate, centrifugally cleaning the precipitate with water for 4-8 times, adding the cleaned precipitate into water with the mass of 5-20 times, uniformly stirring to form slurry, and treating the slurry into micron-sized porous tricalcium phosphate powder by using a spray dryer to obtain the bone repair raw material, wherein the air inlet temperature of the spray dryer is 240-300 ℃, the air outlet temperature is 120-150 ℃, and the feeding rate is 30-200 mL/min.
The micron-sized porous tricalcium phosphate powder has the particle size of 1-20 mu m, is in a porous structure in a microcosmic manner, contains 1-2wt% of magnesium element, preferably 1.3-1.9wt%, shows excellent bioactivity, and effectively promotes new bone formation.
The micron-sized porous tricalcium phosphate powder and the high polymer material (such as collagen) are uniformly mixed to prepare slurry, and the slurry is dried and molded to prepare the molded bone prosthesis.
Example 1
Weighing and dissolving 900g of anhydrous calcium chloride and 270g of magnesium chloride hexahydrate, dissolving in 10L of water to obtain a solution A, weighing 830g of diammonium phosphate, dissolving in 10L of water, and regulating the pH value of the solution to 10.0 by using ammonia water to obtain a solution B.
Heating and mixing, namely heating the solution A and the solution B to 70 ℃ and mixing, and continuously stirring at a rotating speed of 100rpm to form a suspension.
Wet chemical reaction the mixed suspension was heated at 70 ℃ and stirred at 100rpm for 12 hours.
And (3) centrifugal cleaning, namely centrifuging the suspension subjected to wet chemical reaction at 2000rpm for 3 minutes to obtain a precipitate, and adding water for centrifugal cleaning for 5 times.
Spray drying, namely adding the cleaned precipitate into 10L of water, and stirring uniformly to form slurry. Setting the air inlet temperature of a spray dryer to be 250 ℃, setting the air outlet temperature to be 120 ℃, and spray-drying the slurry at the speed of 50mL/min to finally obtain the micron-sized low-density porous tricalcium phosphate powder, wherein the particle size distribution is in the range of 1-20 mu m.
The X-ray diffraction result of the micron-sized low-density porous tricalcium phosphate powder is shown in figure 1, wherein the mass percentage of magnesium element is 1.9%. The micro-morphology of the micron-sized low-density porous tricalcium phosphate powder is shown in fig. 2, the powder is in a porous structure, and the special porous structure can enable the tricalcium phosphate powder to form an interlocking structure with a polymer in the process of preparing the bone prosthesis. Fig. 3 shows a microscopic photograph of a bone prosthesis prepared by mixing the powder material and collagen and adding a crosslinking agent for reaction, and as can be seen from fig. 3, the micron-sized low-density porous tricalcium phosphate powder and collagen form an interpenetrating microstructure, the micron-sized low-density porous tricalcium phosphate powder remarkably improves the binding property with the collagen, and the problems of falling and inflammation of the nano tricalcium phosphate powder in the application process are solved.
Example 2
Weighing and dissolving 1800g of anhydrous calcium chloride and 400g of magnesium chloride hexahydrate, dissolving in 20L of water to obtain a solution A, weighing 1700g of diammonium phosphate, dissolving in 20L of water, and regulating the pH value of the solution to 9.8 by using ammonia water to obtain a solution B.
Heating and mixing, namely heating the solution A and the solution B to 90 ℃ and mixing, and continuously stirring at a rotating speed of 100rpm to form a suspension.
Wet chemical reaction the mixed suspension was heated at 90 ℃ for 4 hours at 100 rpm.
And (3) centrifugal cleaning, namely centrifuging the suspension subjected to wet chemical reaction at 2000rpm for 3 minutes to obtain a precipitate, and adding water for centrifugal cleaning for 5 times.
Spray drying, namely adding the cleaned precipitate into 20L of water, and stirring uniformly to form slurry. Setting the air inlet temperature of a spray dryer to be 270 ℃ and the air outlet temperature to be 140 ℃, and spray-drying the slurry at the speed of 100mL/min to finally obtain the micron-sized low-density porous tricalcium phosphate powder, wherein the particle size distribution is in the range of 1-20 mu m.
The X-ray diffraction result of the micron-sized low-density porous tricalcium phosphate powder is shown in figure 4, wherein the mass percentage of magnesium element is 1.3%.
Comparative example 1
Weighing and dissolving 1800g of anhydrous calcium chloride and 300g of magnesium chloride hexahydrate, dissolving in 20L of water to obtain a solution A, weighing 1700g of diammonium phosphate, dissolving in 20L of water, and regulating the pH value of the solution to 9.3 by using ammonia water to obtain a solution B.
Heating and mixing, namely heating the solution A and the solution B to 90 ℃ and mixing, and continuously stirring at a rotating speed of 100rpm to form a suspension.
Wet chemical reaction the mixed suspension was heated at 90 ℃ for 4 hours at 100 rpm.
And (3) centrifugal cleaning, namely centrifuging the suspension subjected to wet chemical reaction at 2000rpm for 3 minutes to obtain a precipitate, and adding water for centrifugal cleaning for 5 times.
Spray drying, namely adding the cleaned precipitate into 20L of water, and stirring uniformly to form slurry. Setting the air inlet temperature of a spray dryer to be 270 ℃ and the air outlet temperature to be 140 ℃, and spray-drying the slurry at the speed of 100mL/min to finally obtain the micron-sized low-density porous tricalcium phosphate powder.
The X-ray diffraction result of tricalcium phosphate powder is shown in figure 5. As shown in fig. 5, the porous tricalcium phosphate powder contains an impurity phase, mainly calcium hydrogen phosphate impurity phase.
Comparative example 2
The procedure of comparative example 2 was different from that of example 2 in that the pH of the solution was adjusted to 10.8 with ammonia water after dissolving diammonium phosphate in water, and the other steps were the same.
XRD detection was performed on the obtained powder material, and the powder material obtained in comparative example 2 contained a large amount of hydroxyapatite based on the X-ray diffraction result shown in FIG. 6.
As used in this specification and in the claims, the terms "comprises" and "comprising" merely indicate that the steps and elements are explicitly identified, and do not constitute an exclusive list, as other steps or elements may be included in a method or apparatus. The term "and/or" as used herein includes any combination of one or more of the associated listed items.
The endpoints and any values of the ranges disclosed herein are not limited to the precise range or value, and are understood to encompass values approaching those ranges or values. For numerical ranges, one or more new numerical ranges may be found between the endpoints of each range, between the endpoint of each range and the individual point value, and between the individual point value, in combination with each other, and are to be considered as specifically disclosed herein.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. If a definition used herein contradicts or is inconsistent with a definition set forth in other publications, the definition used herein should prevail.
The above-described embodiments are provided for illustrating the technical concept and features of the present invention, and are intended to be preferred embodiments for those skilled in the art to understand the present invention and implement the same according to the present invention, not to limit the scope of the present invention. All equivalent changes or modifications made according to the principles of the present invention should be construed to be included within the scope of the present invention.

Claims (12)

1.一种多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,包括如下步骤:1. A method for preparing a porous magnesium-containing tricalcium phosphate bone repair raw material, characterized in that it comprises the following steps: (i)配制钙盐和镁盐的混合溶液,作为第一溶液;配制磷酸盐溶液,并用碱液调节pH至9.8~10.2,作为第二溶液;(i) preparing a mixed solution of calcium salt and magnesium salt as a first solution; preparing a phosphate solution and adjusting the pH to 9.8-10.2 with an alkali solution as a second solution; (ii)将所述第一溶液和所述第二溶液加热混合,在60~95 ℃及搅拌条件下反应;其中,所述第一溶液和所述第二溶液等体积混合;(ii) heating and mixing the first solution and the second solution, and reacting them at 60-95° C. with stirring; wherein the first solution and the second solution are mixed in equal volumes; (iii)将步骤(ii)反应后获得的悬浊液离心分离取沉淀物,清洗,将清洗后的沉淀物喷雾干燥,得到粉体状的多孔含镁磷酸三钙多孔骨修复原料。(iii) The suspension obtained after the reaction in step (ii) is centrifuged to separate the precipitate, which is then washed and spray-dried to obtain a powdery porous magnesium-containing tricalcium phosphate porous bone repair material. 2.根据权利要求1所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,所述第一溶液中钙离子和镁离子的摩尔比为6~10。2. The method for preparing a porous magnesium-containing tricalcium phosphate bone repair raw material according to claim 1, characterized in that the molar ratio of calcium ions to magnesium ions in the first solution is 6 to 10. 3.根据权利要求2所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,所述第一溶液中钙离子的摩尔浓度为0.01~0.9 mol/L,镁离子的摩尔浓度为0.001~0.15 mol/L。3. The method for preparing a porous magnesium-containing tricalcium phosphate bone repair material according to claim 2, characterized in that the molar concentration of calcium ions in the first solution is 0.01~0.9 mol/L, and the molar concentration of magnesium ions is 0.001~0.15 mol/L. 4.根据权利要求1至3任一项所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,所述第一溶液和所述第二溶液混合后,钙离子和磷酸根离子的摩尔比为1.1~1.5。4. The method for preparing a porous magnesium-containing tricalcium phosphate bone repair material according to any one of claims 1 to 3, characterized in that after the first solution and the second solution are mixed, the molar ratio of calcium ions to phosphate ions is 1.1 to 1.5. 5.根据权利要求4所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,所述第二溶液中磷酸盐的摩尔浓度为0.008~0.8 mol/L。5. The method for preparing a porous magnesium-containing tricalcium phosphate bone repair material according to claim 4, characterized in that the molar concentration of phosphate in the second solution is 0.008-0.8 mol/L. 6.根据权利要求1至3任一项所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,所述钙盐选自无水氯化钙、二水合氯化钙和四水合硝酸钙中的一种或多种的组合,所述镁盐选自六水合氯化镁和/或六水合硝酸镁,所述磷酸盐选自磷酸氢二钠、磷酸氢二铵和磷酸氢钠中的一种的多种的组合,所述碱液为氨水或氢氧化钠。6. The method for preparing a porous magnesium-containing tricalcium phosphate bone repair raw material according to any one of claims 1 to 3, characterized in that the calcium salt is selected from a combination of one or more of anhydrous calcium chloride, calcium chloride dihydrate and calcium nitrate tetrahydrate, the magnesium salt is selected from magnesium chloride hexahydrate and/or magnesium nitrate hexahydrate, the phosphate is selected from a combination of one or more of disodium hydrogen phosphate, diammonium hydrogen phosphate and sodium hydrogen phosphate, and the alkali solution is ammonia water or sodium hydroxide. 7.根据权利要求1所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,步骤(i)中,使用氨水将所述第二溶液的pH调节至9.8~10.2。7 . The method for preparing a porous magnesium-containing tricalcium phosphate bone repair material according to claim 1 , wherein in step (i), ammonia water is used to adjust the pH of the second solution to 9.8-10.2. 8.根据权利要求1所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,步骤(ii)中,将所述第一溶液和所述第二溶液加热至60~95 ℃后混合。8 . The method for preparing the porous magnesium-containing tricalcium phosphate bone repair material according to claim 1 , characterized in that in step (ii), the first solution and the second solution are heated to 60-95° C. and then mixed. 9.根据权利要求1或8所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,步骤(ii)中,搅拌速率为100~500 rpm。9 . The method for preparing the porous magnesium-containing tricalcium phosphate bone repair material according to claim 1 or 8 , characterized in that in step (ii), the stirring rate is 100-500 rpm. 10.根据权利要求1所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,步骤(iii)中,使用喷雾干燥机将清洗后的沉淀物喷雾干燥,所述喷雾干燥机的进风温度为240~300 ℃,出风温度为120~150 ℃,进料速率为30~200 mL/min。10. The method for preparing a porous magnesium-containing tricalcium phosphate bone repair material according to claim 1, characterized in that in step (iii), a spray dryer is used to spray dry the washed precipitate, the inlet air temperature of the spray dryer is 240-300°C, the outlet air temperature is 120-150°C, and the feed rate is 30-200 mL/min. 11.根据权利要求1或10所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,步骤(iii)中,所述沉淀物加入水中离心清洗多次,将清洗后的沉淀物加入5~20倍质量的水中,搅拌均匀形成浆料,再喷雾干燥。11. The method for preparing a porous magnesium-containing tricalcium phosphate bone repair material according to claim 1 or 10, characterized in that in step (iii), the precipitate is added to water and centrifuged and washed multiple times, the washed precipitate is added to 5 to 20 times the mass of water, stirred evenly to form a slurry, and then spray-dried. 12.根据权利要求1所述的多孔含镁磷酸三钙骨修复原料的制备方法,其特征在于,所述制备方法具体实施如下:12. The method for preparing the porous magnesium-containing tricalcium phosphate bone repair material according to claim 1, characterized in that the preparation method is specifically implemented as follows: 将钙盐和镁盐溶解在水中,得到第一溶液,其中钙盐的浓度为1~100 g/L,镁盐的浓度为0.4~40 g/L;Dissolving a calcium salt and a magnesium salt in water to obtain a first solution, wherein the concentration of the calcium salt is 1-100 g/L, and the concentration of the magnesium salt is 0.4-40 g/L; 将磷酸盐溶解在水中,使用氨水调节pH至9.8~10.2,得到第二溶液,其中磷酸盐的浓度为1~100 g/L;Dissolving phosphate in water, and adjusting the pH to 9.8-10.2 with aqueous ammonia to obtain a second solution, wherein the concentration of phosphate is 1-100 g/L; 将相等体积的第一溶液和第二溶液加热至60~95 ℃后混合,在搅拌条件下常压反应,其中搅拌速率为100~500 rpm;The first solution and the second solution of equal volume are heated to 60-95°C and then mixed, and reacted under normal pressure with stirring, wherein the stirring rate is 100-500 rpm; 将反应后的悬浊液离心分离取沉淀物,用水离心清洗4~8次,将清洗后的沉淀物加入5~20倍质量的水中,搅拌均匀形成浆料,使用喷雾干燥机将所述浆料处理为微米级多孔含镁磷酸三钙粉体,即得所述多孔含镁磷酸三钙骨修复原料,其中喷雾干燥机的进风温度为240~300 ℃,出风温度为120~150 ℃,进料速率为30~200 mL/min。The suspension after the reaction is centrifuged to obtain a precipitate, which is centrifugally washed with water for 4 to 8 times, and the washed precipitate is added to 5 to 20 times the mass of water, stirred evenly to form a slurry, and the slurry is processed into a micron-sized porous magnesium-containing tricalcium phosphate powder using a spray dryer to obtain the porous magnesium-containing tricalcium phosphate bone repair raw material, wherein the inlet temperature of the spray dryer is 240 to 300 ° C, the outlet temperature is 120 to 150 ° C, and the feed rate is 30 to 200 mL/min.
CN202311096242.0A 2023-08-29 2023-08-29 Preparation method of bone repair raw material, bone repair raw material and application thereof Active CN117122734B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202311096242.0A CN117122734B (en) 2023-08-29 2023-08-29 Preparation method of bone repair raw material, bone repair raw material and application thereof
PCT/CN2024/114504 WO2025044976A1 (en) 2023-08-29 2024-08-26 Artificial bone repair material, porous magnesium-containing tricalcium phosphate powder and preparation method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311096242.0A CN117122734B (en) 2023-08-29 2023-08-29 Preparation method of bone repair raw material, bone repair raw material and application thereof

Publications (2)

Publication Number Publication Date
CN117122734A CN117122734A (en) 2023-11-28
CN117122734B true CN117122734B (en) 2025-05-16

Family

ID=88850349

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311096242.0A Active CN117122734B (en) 2023-08-29 2023-08-29 Preparation method of bone repair raw material, bone repair raw material and application thereof

Country Status (1)

Country Link
CN (1) CN117122734B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025044976A1 (en) * 2023-08-29 2025-03-06 常州邦莱医疗科技有限公司 Artificial bone repair material, porous magnesium-containing tricalcium phosphate powder and preparation method therefor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008162892A (en) * 2002-08-22 2008-07-17 Japan Science & Technology Agency Calcium phosphate porous spherical particles and calcium phosphate porous multilayer spherical particles partially substituted or surface-supported with metal ions
CN116133861A (en) * 2020-07-30 2023-05-16 富田制药株式会社 Calcium phosphate powder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891198A (en) * 1986-08-07 1990-01-02 General Foods Corporation Preparation of tricalcium phosphate
JP2004099433A (en) * 2002-08-22 2004-04-02 Japan Science & Technology Agency Calcium phosphate porous spherical particles and calcium phosphate porous multilayer spherical particles partially substituted or surface-supported by metal ions
US7670579B2 (en) * 2004-04-06 2010-03-02 American Dental Association Foundation Nanostructured bioactive materials prepared by dual nozzle spray drying techniques
CN100445201C (en) * 2006-10-16 2008-12-24 南京工业大学 A kind of preparation method of nanometer amorphous calcium phosphate powder
CN111346262B (en) * 2020-03-17 2022-02-01 四川大学 Injectable calcium-phosphorus ceramic for promoting healing of tendon and bone and preparation method and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008162892A (en) * 2002-08-22 2008-07-17 Japan Science & Technology Agency Calcium phosphate porous spherical particles and calcium phosphate porous multilayer spherical particles partially substituted or surface-supported with metal ions
CN116133861A (en) * 2020-07-30 2023-05-16 富田制药株式会社 Calcium phosphate powder

Also Published As

Publication number Publication date
CN117122734A (en) 2023-11-28

Similar Documents

Publication Publication Date Title
CN107902636B (en) Selenium-doped hydroxyapatite and preparation method thereof
CN101486452B (en) Preparation of nano hydroxylapatite powder
CN117122734B (en) Preparation method of bone repair raw material, bone repair raw material and application thereof
CN106115642B (en) A kind of large scale hydroxyapatite porous microsphere material and preparation method thereof
JP7084058B2 (en) Method for producing octacalcium phosphate and octacalcium phosphate produced thereby
CN104961114B (en) Calcium and magnesium phosphate nano structural material and preparation method thereof
CN106390190A (en) Process for manufacturing alpha-tricalcium phosphate-alpha-calcium sulfate hemihydrates bone cement porous bracket through squashing method
JP2004026648A (en) Method for manufacture alpha- and beta-tricalcium phosphate powder
JPH1121125A (en) Fine thin plate-like boehmite particles and method for producing the same
CN116832219B (en) Artificial bone repair material and preparation method thereof
CN1308016A (en) Preparation of low temperature sinterable hydroxyapatite powder
CN117298334A (en) Artificial bone prosthesis based on 3D printing and preparation method thereof
CN107021465B (en) A kind of preparation method of the calcium salt admixture as biomaterial
CN115784734A (en) High-purity beta-TCP powder and preparation method thereof
CN110510592A (en) Method for regulating the preparation of hydroxyapatite with excellent cytocompatibility
CN114890445B (en) Method for synthesizing superfine magnesium hydroxide by continuous liquid film
CN105152151B (en) A kind of method that β tricalcium phosphates are prepared based on multi-D swing nano ball grinding
CN104477867A (en) Nano-hydroxyapatite synthesized and stably existing in weak acid environment
CN108751155A (en) The preparation method of the hydroxyapatite of size tunable
CN103723699A (en) Preparation method of structure size-controllable hydroxyapatite powder for plasma thermal spraying
WO2025044976A1 (en) Artificial bone repair material, porous magnesium-containing tricalcium phosphate powder and preparation method therefor
CN101007627A (en) Ion thermal synthesis method for nano hydroxy apatite
KR20200130083A (en) Method for preparing transition metal oxide fine particles
CN104386661B (en) A kind of preparation method of structure-controllable hydroxyapatite micro-sphere
CN116216681B (en) A preparation method of basic ammonium ferric phosphate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant